Skip to main content
WeightCited

Chromium per Insulin Resistance

B

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

Key Statistics

25

Studi

2000

Partecipanti

Positive

B

Grado

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
25-35 mcg/day (AI)
weightmanagement:
200-1,000 mcg/day chromium picolinate
insulinsensitivity:
500-1,000 mcg/day

Limite massimo: No established UL; long-term safety data at >1,000 mcg/day limited

Momento migliore per l'assunzione: With meals

Safety & Side Effects

Effetti collaterali segnalati

  • Headache
  • Insomnia
  • Mood changes
  • GI discomfort

Interazioni note

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • Insulin
  • Sulfonylureas
  • Levothyroxine (reduced absorption)

Livello di assunzione massimo tollerabile: No established UL; long-term safety data at >1,000 mcg/day limited

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Chromium help with Insulin Resistance?
Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
How much Chromium should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chromium?
Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chromium and Insulin Resistance?
We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.